Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Solid State sees strong orders in security & defence

Wed, 06th Sep 2023 16:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Malin Corporation PLC - Dublin-based investor in life sciences companies - Estimated intrinsic equity value per share at June 30 was EUR6.25, compared to EUR9.34 at December 31 2022. Notes decrease was primarily attributable to the decline in the public market share price of Poseida in that period. Estimates intrinsic equity value per share at September 4 was EUR6.49, a 4% increase compared to June 30. This reflects a modest increase in the share price of Poseida following the announcement of a USD50 million strategic investment by Astellas in Poseida in August 2023.

----------

Beeks Financial Cloud Group PLC - Glasgow-based cloud computing and connectivity provider - Expects revenue for financial year 2023 to be over 20% higher than the year before, delivering underlying earnings before interest, tax, depreciation and amortisation growth of over 35% and underlying pretax profit growth of around 10%. Achieved a positive free cash flow position in the second half of the year in line with expectations, with net cash of GBP4.4 million, at the period end, compared to GBP3.4 million at the end of the first half. Adds the pipeline of opportunities for each of its offerings is significant and growing. Believes exchange cloud remains a potentially transformational opportunity.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Reports a strong start to the financial year across both divisions. Highlights particularly strong order intake in the security & defence sector, with the medical sector continuing to see good demand and new design opportunities. Continues to maintain a strong balance sheet which provides the business with advantageous commercial and competitive strength for working capital needs and M&A opportunities. Remains ambitious and continues to review acquisition opportunities and organic growth initiatives, with a view to meeting its new 2030 strategic objective of maintaining compound annual growth in total shareholder return in excess of 20%.

----------

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - States whilst it maintains a very strong order book, one of its leading products, the FoodPrint test, had some production challenges towards the end of the year which resulted in a drop in production yields. This resulted in a backlog in the fulfilment of some orders. New processes have now been brought in, boosting production, to successfully address the order backlog. Remains well-funded to deliver against strategic objectives and is implementing the final parts of the turnaround strategy outlined last year. Continues to vigorously pursue its substantial counterclaim for losses incurred towards the DHSC, as a direct result of its failure to licence the necessary intellectual property to permit the contract to move forward and their failure to notify the group of their inability to do so in a timely manner.

----------

M Winkworth PLC - London-based estate agent - Reports Winwkorth revenue in the six months to June 30 of GBP4.3 million, unchanged from the year before. Pretax profit of GBP811,000 was down 24% from GBP1.1 million with basic earnings per share of 4.33 pence, down 31% from 6.26p. Says gross revenue from its franchised network of GBP26.4 million, down 5% from GBP27.7 million the year before. Explains sales transactions in the first half of this year were constrained by a backdrop of rising interest rates, mitigated to a degree by the trend towards fixed term mortgages. Anticipates that the number of completions will firm up as the year progresses.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
13 Feb 2014 10:26

STOCKS NEWS EUROPE-UK small caps lag AIM-listed shares

Junior-listed AIM shares rise 0.3 percent, outperforming the FTSE Small Cap index, down 0.3 percent, the mid-caps, down 0.7 percent, and the blue chips, which fall 0.6 percent. Troubled Czech coalminer New World Resources drops 6.9 percent, the top small cap faller, after posting a record 4

Read more
13 Feb 2014 09:24

Omega Diagnostics Completes CD4 Technology Transfer Project

LONDON (Alliance News) - Omega Diagnostics Group PLC said Thursday that it had completed its CD4 technology transfer project, having successfully completed a three-batch validation of its manufacturing protocol. The medical diagnostics company has been undertaking a number of experiments to

Read more
27 Nov 2013 11:26

Omega Diagnostics Confident For Next Year But Cautious On This One

Read more
27 Nov 2013 09:39

STOCKS NEWS EUROPE-UK small caps rise, lagging blue-chips

The FTSE Small Caps Index edges up by 0.2 percent in early session trading, slightly lagging a 0.4 percent advance on the blue-chip FTSE 100 index and underperforming a 0.6 percent rise on the FTSE 250 mid-caps index . The junior-listed FTSE AIM All Share Index slips 0.1 percent. Paw

Read more
27 Nov 2013 07:57

AIM IN BRIEF: Albemarle & Bond Sees No Signs Of Recovery

Read more
31 Oct 2013 14:21

Omega Diagnostics Expects To Complete CD4 Technology Transfer By End December

Read more
17 Oct 2013 09:11

Omega Diagnostics Expects Full-Year Revenues Of GBP5.6 Million

Read more
1 Jul 2013 07:53

Omega hurt by weak UK, European markets

Medical diagnostics firm Omega said full year profit tumbled 22 per cent following a slowdown in growth in European markets. Adjusted profit before tax fell to £0.78m in the year to the end of March from £1.0m in 2012. Annual turnover was little changed at £11.3m compared to £11.1m previously. Gr

Read more
24 May 2013 09:21

Omega Diagnostics raises funds for research and development

Medical company Omega Diagnostics Group has raised four million pounds through the placement of over 23m shares which will be used to fund the development of new products. The company, focused on developing diagnostics for allergies, food intolerances and infectious diseases, said it intends to use

Read more
19 Nov 2012 15:04

Omega Diagnostics awarded grant for HIV test

Omega Diagnostics has been awarded a grant of up to 150,000 pounds from Scottish Enterprise to help scale up manufacturing facilities for the company's new CD4 test for monitoring HIV positive patients. The facility will be located at the company's headquarters in Alva, Central Scotland and the gr

Read more
2 Jul 2012 16:42

Omega Diagnostics unveils strong year

Medical diagnostics group Omega Diagnostics posted a strong set of full year results which saw turnover rise 41 per cent and gross profit leap 49 per cent. Pre-tax profits came in at £0.48m (2011: £0.12m) on revenues of £11.1m, compared with £7.9m the previous year. Earning per share rose from 0.1

Read more
16 Apr 2012 10:58

Small caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...

The cash-point marketing company i-design said that revenues for the first half of its current financial year will be ahead of the same period of 2011. The group creates advertising solutions for banks and third parties through cash-point screens. A new contract with a Canadian bank has boosted turn

Read more
26 Nov 2010 15:49

Omega Diagnostics grows profit by 53%

Omega Diagnostics has pushed up its interim profit and there will be more to come when it completes the acquisition of a Germany-based allergy testing business. Revenues grew from £2.87m to £3.3m in the six months to September 2010, while underlying profit jumped from £263,000 to £403,000. That pro

Read more
17 Nov 2010 14:31

Small caps round-up: Judges Scientific, Media Corp, Omeda Diagnostics...

Scientific instruments designer Judges Scientific revealed that trading has continued to be "favourable" and adjusted earnings in respect of 2010 are likely to exceed current market expectations. Additionally, gas purifier and calibration equipment provider Sircal Instruments, acquired in March, has

Read more
13 Oct 2010 15:17

Small caps round-up: Tri-Star

Mining company Tri-Star has entered into an agreement with a Turkish contractor to undertake a 17-hole diamond drilling programme of the company's Goynuk antimony mine. Shares in Omega Diagnostics, which specialises in the diagnosis of diseases such as syphilis and TB, soared 16% after it reporte

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.